Download presentation
Presentation is loading. Please wait.
Published byRebecca Thompson Modified over 9 years ago
1
LUNG CANCER 2003-2006
2
Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, All Cases n=1364 Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH **Non-Analytic - Initially diagnosed & treated elsewhere to JHH for treatment of recurrent, metastatic or progression of disease.
3
Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, All Cases by Class of Case, n=1364 MaleFemaleTotal Class 0 251338 Class 1 390335725 Class 2 245217462 Class 3 7366139 Total7336311364 Analytic: Class 0, 1, 2 Non-Analytic: Class 3
4
Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, All Cases Age at Diagnosis n=1364 72 130 202 158 55 10/10 4/466 149 236 199 69
5
Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, All Cases by Race n=1364 460 531 149 178 4/8 18/16
6
Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, All Cases Maryland by County n=1018
7
Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, All Cases by State n=1364
8
Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, Analytic Class 1 & 2 by AJCC Stage n=1182 157 175 38 31 141 176 231 169 39 25 There were 4 class 0
9
Johns Hopkins Hospital Lung Cancer, Non-Small Cell 2003-2006, Analytic Class 1&2 by Treatment, n=1182
10
Johns Hopkins Hospital Lung Cancer, Non-Small Cell JHH vs MD vs National Treatment, AJCC I 2003-2004 Percentage % Maryland JHHNational Surgery Only68.6 79.863.7 Radiation5.8 2.19.5 Radiation & Chemotherapy3.2 1.54.8 Chemotherapy only2.0 0.91.9 Surgery, Radiation & Chemotherapy1.4 1.81.7 Other9.9 13.58.0 No Treatment9.0 0.310.2 TOTAL100 100100 Source NCDB, Commission on Cancer, ACoS/ACS
11
Johns Hopkins Hospital Lung Cancer, Non-Small Cell JHH vs MD vs National Treatment, AJCC II 2003-2004 Percentage % Maryland JHHNational Surgery Only12.4 30.433.8 Radiation8.3 2.99.8 Radiation & Chemotherapy32.4 1.412.8 Chemotherapy only13.6 4.33.4 Surgery, Radiation & Chemotherapy10.3 15.99.5 Other9.1 43.420.0 No Treatment13.9 1.410.6 TOTAL100 100100 Source NCDB, Commission on Cancer, ACoS/ACS
12
Johns Hopkins Hospital Lung Cancer, Non-Small Cell JHH vs MD vs National Treatment, AJCC III 2003-2004 Percentage % Maryland JHHNational Surgery Only5.7 12.06.7 Radiation9.1 8.413.4 Radiation & Chemotherapy38.6 24.735.4 Chemotherapy only14.7 17.511.8 Surgery, Radiation & Chemotherapy8.6 13.36.2 Other6.4 15.97.1 No Treatment16.8 8.119.3 TOTAL100 100100 Source NCDB, Commission on Cancer, ACoS/ACS
13
Johns Hopkins Hospital Lung Cancer, Non-Small Cell JHH vs MD vs National Treatment, AJCC IV 2003-2004 Percentage % Maryland JHHNational Surgery Only2.5 3.21.7 Radiation19.1 17.922.1 Radiation & Chemotherapy20.9 23.824.2 Chemotherapy only23.0 24.619.7 Surgery, Radiation & Chemotherapy1.2 4.91.0 Other5.3 12.04.6 No Treatment27.9 13.526.6 TOTAL100 100100 Source NCDB, Commission on Cancer, ACoS/ACS
14
Johns Hopkins Hospital Lung Cancer, Non-Small Cell, 1998-1999, Analytic Class 1&2. Relative Survival n=474
15
Relative 5 Year Survival Lung Cancer, Non-Small Cell, 1998-1999, State of Maryland, n = 3382 Source NCDB, Commission on Cancer, ACoS/ACS
16
Relative 5 Year Survival Lung Cancer, Non-Small Cell, 1998-1999, Teaching Hospitals, n = 52313 Source NCDB, Commission on Cancer, ACoS/ACS
17
Relative 5 Year Survival NSCLC 1998-1999, JHH vs MD vs National AJCC Stage I Source NCDB, Commission on Cancer, ACoS/ACS
18
Relative 5 Year Survival NSCLC 1998-1999, JHH vs MD vs National AJCC Stage II Source NCDB, Commission on Cancer, ACoS/ACS
19
Relative 5 Year Survival NSCLC 1998-1999, JHH vs MD vs National AJCC Stage III Source NCDB, Commission on Cancer, ACoS/ACS
20
Relative 5 Year Survival NSCLC 1998-1999, JHH vs MD vs National AJCC Stage IV Source NCDB, Commission on Cancer, ACoS/ACS
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.